S&P MidCap 400 Constituent Ciena Will Replace Dayforce In The S&P500; S&P SmallCap 600 Constituent Arrowhead Pharmaceuticals Will Replace Ciena In The S&P MidCap 400, And ADT Inc. Will Replace Arrowhead Pharmaceuticals In The S&P SmallCap 600 Effective Prior To The Opening Of Trading On February 9

Benzinga · 2d ago
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.